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Versatile cell‑based assay 
for measuring DNA alkylation 
damage and its repair
Yong Li6,7, Peng Mao1,8, Evelina Y. Basenko4,9, Zachary Lewis2,3,4, Michael J. Smerdon1 & 
Wioletta Czaja1,5,7*
DNA alkylation damage induced by environmental carcinogens, chemotherapy drugs, or endogenous 
metabolites plays a central role in mutagenesis, carcinogenesis, and cancer therapy. Base excision 
repair (BER) is a conserved, front line DNA repair pathway that removes alkylation damage from 
DNA. The capacity of BER to repair DNA alkylation varies markedly between different cell types 
and tissues, which correlates with cancer risk and cellular responses to alkylation chemotherapy. 
The ability to measure cellular rates of alkylation damage repair by the BER pathway is critically 
important for better understanding of the fundamental processes involved in carcinogenesis, and also 
to advance development of new therapeutic strategies. Methods for assessing the rates of alkylation 
damage and repair, especially in human cells, are limited, prone to significant variability due to the 
unstable nature of some of the alkyl adducts, and often rely on indirect measurements of BER activity. 
Here, we report a highly reproducible and quantitative, cell‑based assay, named alk‑BER (alkylation 
Base Excision Repair) for measuring rates of BER following alkylation DNA damage. The alk‑BER 
assay involves specific detection of methyl DNA adducts (7‑methyl guanine and 3‑methyl adenine) 
directly in genomic DNA. The assay has been developed and adapted to measure the activity of 
BER in fungal model systems and human cell lines. Considering the specificity and conserved nature 
of BER enzymes, the assay can be adapted to virtually any type of cultured cells. Alk‑BER offers a 
cost efficient and reliable method that can effectively complement existing approaches to advance 
integrative research on mechanisms of alkylation DNA damage and repair.
DNA alkylation induced by methylating agents such as environmental carcinogens (e.g., smoke), by-products 
of cellular metabolism (e.g., methyl group donor S-adenosyl methionine), or chemotherapy drugs (e.g., temo-
zolomide, procarbazine) represents one of the most abundant types of DNA base damage that forms in human 
cells. Monofunctional alkylating agents, like methyl methanesulfonate (MMS) or the anticancer drug temozo-
lomide (TMZ) induce formation of N-methyl and O-methyl DNA adducts such as N7-methylguanine (7meG), 
N3-methyladenine (3meA) and O6-methylguanine (O6meG)1,2. Methyl DNA adducts (MDAs) have cytotoxic 
and mutagenic properties because of their ability to block gene transcription and interfere with the fidelity of 
DNA replication. Persistent and inefficiently repaired methyl DNA adducts can induce microsatellite instability, 
frameshift mutations, and G → A transition mutations, that are commonly found in genes critical for malignant 
transformation, including the H-ras oncogene or TP53 tumor suppressor  gene3–5. Despite their carcinogenic 
properties, DNA alkylating agents, such as dacarbazine, temozolomide and streptozotin, have been used for 
decades in treating various cancers, including melanoma, glioma, and  lymphoma2,6,7. Therapy with alkylating 
agents can be effective; however, these agents are extremely toxic and prolonged treatment often leads to chem-
oresistance and formation of secondary  cancers8,9. Human responses to alkylating agents vary considerably 
between individuals, which highlights the involvement of genetic and epigenetic mechanisms in the modulation 
of cellular toxicity to alkylating  agents2,10,11.
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Base excision repair (BER) is the primary pathway involved in the removal of alkylation DNA damage induced 
by methylating  agents2,12,13. Repair of methyl DNA adducts through the BER pathway is accomplished in four 
sequential steps, each carried out by a specific group of  enzymes14. The first step is catalyzed by DNA glycosylases 
(e.g., AAG), which specifically recognize and bind to a damaged base, and subsequently catalyze cleavage of the 
glycosidic bond between the damaged base and DNA  backbone15,16. This reaction results in the release of the 
damaged base from DNA, and the formation of abasic AP (apurinic/apyridiminic) sites. The second step involves 
incision of the DNA backbone 5’ upstream of the AP sites by AP endonucleases (e.g., APE1), which results in 
the formation of single strand DNA breaks (SSBs)17,18. In mammalian cells, AP sites and SSBs are recognized by 
poly ADP-ribose polymerase 1 (PARP1)19,20. Activated PARP1 catalyzes the formation of ADP-ribose chains, 
which serve as a docking platform that facilitates recruitment and assembly of the multiprotein BER complex 
(XRCC1-POLβ-LIG3). Breaks in DNA are filled in by DNA polymerases (primarily POLβ) using the undam-
aged complementary DNA strand as a  template21. Nicks in the damaged strand are sealed by ligases (e.g., LIG3), 
which finalizes repair of the damaged DNA  strand22,23.
Importantly, methylation-derived repair intermediates such as AP sites and SSBs are highly cytotoxic and 
mutagenic. Therefore, individual steps in the BER pathway need to be tightly regulated and coordinated to 
prevent accumulation of those intermediates, cell death, mutagenesis, and  carcinogenesis2,24. Genetic studies in 
yeast, mouse models, and human cells have demonstrated that loss of the tight coordination between individual 
steps in the BER pathway can trigger genome instability, increased mutagenesis, or cell  death2,5,24–27. Levels and 
activities of BER proteins vary significantly between cells, tissues, and individuals and correlate with cancer risk 
and response to alkylation  chemotherapy2,10,11,25,28–32. Therefore, measuring and understanding differences in the 
rate of BER upon alkylation DNA damage could contribute to the development of new approaches in personal-
ized disease prevention and treatment.
The BER pathway is dysregulated in many cancers and is often associated with cancer heterogeneity, 
metastasis, and chemoresistance. Pharmacological inhibition of BER with PARP inhibitors (e.g., olaparib) has 
shown enhanced cytotoxicity of various anticancer agents, especially in tumors with defects in homologous 
 recombination33–37. Identifying a pre-existing BER imbalance within a tumor may be highly relevant for deter-
mining whether therapy involving PARP inhibitors and alkylating agents can be beneficial.
Quantitation of DNA adduct formation and repair has greatly advanced our understanding of DNA repair 
processes. A number of methods have been developed for quantitative analysis of various enzymatic steps and 
the overall capacity of BER to repair alkylation DNA damage. The most sensitive methods for detection and 
quantitation of alkyl DNA adducts include HPLC/32P-postlabeling, mass spectrometry-based adductomics, and 
 radiolabeling38–41. These methods offer high sensitivity; however, they require specialized equipment, expertise, 
and complex sample preparation, which hinders the convenient use of those approaches to investigate cellular 
BER mechanisms.
The most commonly used cell-based methods to investigate BER, include comet assays and host cell reac-
tivation (HCR) assays. The comet assay is a single-cell electrophoresis technique that can be used to assess the 
capacity of BER to repair alkylation DNA damage when performed under alkaline  conditions42. This assay 
can be used to analyze total levels of BER repair intermediates, such as alkali labile sites (e.g., abasic sites) and 
single strand breaks; however, it does not quantitatively distinguish between these intermediates. The standard 
comet assay may not reliably detect persistent and intact base modifications (e.g., 7meG or 3meA) that are not 
converted to AP sites or SSBs. In addition, the comet assay may not detect lesions that form and persist within 
highly inaccessible heterochromatin fractions of the genome. Furthermore, the standard comet assay workflow is 
laborious and prone to day-to-day variability. It may also require extensive optimization of experimental condi-
tions, including pH or salts used during the alkaline electrophoresis steps, to achieve sensitivity and consistent 
 reproducibility42,43. HCR is another method that has been used to measure the capacity of BER to repair alkyla-
tion DNA damage in living  cells44,45. HCR relies on the transfection of the non-replicating DNA plasmid with a 
reporter gene (e.g., luciferase) that contains chemically-induced DNA base damage, which is subject to repair by 
the BER pathway. The presence of the DNA base damage within the reporter gene inhibits its expression, whereas 
the repair of base damage re-activates reporter expression. The HCR assay can be especially challenging to assess 
repair of alkylation DNA damage, due to in vitro instability of the alkyl DNA adducts (e.g., 7meG and 3meA), 
which can markedly affect assay  reproducibility45. Also, HCR involves a non-genomic DNA substrate that does 
not necessarily reflect the complexity of the genomic chromatin environment.
More recently, high resolution, high throughput approaches such as LAF-seq (Lesion-Adjoining Fragment 
Sequencing) or NMP-seq (N-methyl purine sequencing) utilizing next generation DNA sequencing have been 
developed to enable precise mapping and quantitation of methyl DNA adducts across the genome, and at specific 
genomic  loci46,47. These approaches offer unprecedented single base resolution, but can be laborious, involving 
generation of DNA sequencing libraries and extensive bioinformatics analyses of the sequencing data, especially 
when used with human cells. In addition, those methods may require high (non-physiological) doses of DNA 
damaging agents and large amounts of input DNA.
Here we report a reliable, gel-based method, called alk-BER, that offers a fast and quantitative measure of BER 
capacity in living cells. Alk-BER was developed by an adaptation of a previous methods for UV-induced DNA 
damage quantitation by alkaline gel electrophoresis, originally developed by Sutherland et al.48. We developed a 
set of optimized protocols to analyze formation and repair of alkylation-induced DNA damage in various model 
organisms, including fungal cells (S. cerevisiae, N. crassa) and human cancer cell lines.
Alk-BER can be used to assess overall capacity of BER to repair MMS-induced alkylation DNA damage 
within the genome of living cells. It should be noted that alk-BER assay does not directly measure activity of 
the endogenous BER enzymes in the repair of DNA alkylation damage, but it measures changes in the levels of 
DNA alkylation in the genomic DNA that strongly correlate with the capacity of the BER pathway to directly 
and specifically repair DNA alkylation in the genomic DNA. The assay can be used to facilitate identification of 
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new, conserved regulators of the BER pathway by using complementary model eukaryotic systems, including 
fungal model organisms and human cells. Application of the alk-BER assay could also facilitate identification of 
BER-deficient cancer sub-types, which might represent suitable targets for therapy with alkylating agents and/
or PARP inhibitors.
Materials and methods
DNA damage and time course of repair in yeast cells. Yeast (S. cerevisiae) liquid cell cultures were 
inoculated from single colonies and grown in 10 ml of YPD (Yeast extract -Peptone-Dextrose) medium for ~ 16 h 
at 30 °C in an orbital shaker. The following day, cells were sub-cultured in fresh media and grown until the cul-
tures reached the logarithmic stage of growth, as determined by measuring the optical density of the cell culture 
(e.g.,  OD600 ~ 0.6). Next, MMS was added to the liquid cultures at a final concentration of 20 mM and cells were 
incubated for 10 min at 30 °C in an orbital shaker. Alternatively, cells were treated with 3.5 mM MMS for 1–3 h, 
followed by removal of media containing MMS and repair time course in fresh media for 1–6 h. Cells were then 
harvested by centrifugation, and the supernatant fractions containing MMS were removed and disposed follow-
ing DEHS guidelines. Cell pellets were washed with ice-cold phosphate buffered saline (1X PBS), re-suspended 
in a pre-warmed YPD media, and allowed to repair for a total of 3 h. Extended repair time points (longer than 
4–5 h) were avoided to ensure that restoration of the genome integrity was due to the activity of BER, and not 
due to lesion bypass and DNA replication. Cultures were incubated with continuous shaking and cell aliquots 
were collected at different repair time  points49,50.
Yeast genomic DNA isolation. Yeast genomic DNA was extracted with the glass bead method following 
previously established  protocols51. Briefly, cell pellets were mixed with 250 μL of DNA lysis buffer [2% (vol/vol) 
Triton X-100, 1% SDS, 100 mM NaCl, 10 mM Tris·HCl, pH 8.0, 1 mM EDTA, 250 μL of PCI (phenol: chloro-
form: isoamyl alcohol = 25:24:1), and 150 μL of acid-washed glass beads, and vortexed vigorously for 4 min. 
Next, 200 μL of 1XTE buffer (10 mM Tris·HCl, pH 7.5, 1 mM EDTA) were added and cell lysates were centri-
fuged at 14,000 rpm at 4 °C. The supernatant fraction was transferred to a fresh Eppendorf tube and mixed with 
1 mL of ice-cold 200 proof ethanol. Samples were incubated at − 80 °C for 15 min to facilitate formation of the 
DNA precipitate. Next, samples were centrifuged at 14,000 rpm at 4 °C, and washed with 70% (vol/vol) ethanol. 
The DNA pellets were dissolved in 200 μL of 1XTE buffer and incubated with 2 μL of RNase A (Thermo Fisher 
Scientific, cat # EN0531) at 37 °C for 1 h to remove RNA. DNA was subsequently ethanol-precipitated, dissolved 
in sterile deionized  H2O, and then stored at − 80 °C.
AAG and APE1 reactions. Purified genomic DNA was processed with (+) or without (−) an enzymatic 
cocktail composed of AAG (New England BioLabs, cat# M0313S) and APE1 (New England BioLabs, cat# 
M0282), to convert MMS-induced 7meG and 3meA to SSBs. DNA samples (0.6–1 μg) were incubated with 1 
μL of AAG and 1 μL of APE1 in the reaction buffer (70 mM MOPS, pH 7.5,1 mM dithiothreitol (DTT), 1 mM 
EDTA, 5% glycerol) at 37 °C for 1 h in a total reaction volume of 20 μL52. Methylated bases were cleaved by 
AAG glycosylase and the resulting abasic sites were cleaved by APE1 endonuclease. The reactions were stopped 
by adding DNA loading buffer (50 mM NaOH, 1 mM EDTA, 3% Ficoll, 0.025% Bromocresol green, 0.041% 
Xylene cyanol). Following enzymatic digestion of DNA cleavage products, single and double strand breaks were 
resolved on 1.2% alkaline agarose gels and stained with SYBR  Gold49,50.
Alkaline agarose gel electrophoresis. Alkaline agarose gel electrophoresis was performed following 
previously published protocols with  modifications48,53. The large gel electrophoresis box and casting tray were 
used. The agarose solution was prepared by adding 4.3 g of agarose to 360 ml of  H20 in a 1 L Erlenmeyer flask 
and then heating in a microwave oven until the agarose was dissolved. The solution was cooled to 55 °C and then 
followed by addition of a 0.1 volume (40 ml) of 10X alkaline agarose gel electrophoresis buffer (500 mM NaOH, 
10 mM EDTA, pH 8.0). Addition of 10X alkaline buffer to a hot agarose solution should be avoided because 
NaOH in the buffer may cause hydrolysis of the agar. The agarose solution was poured into a large gel casting 
tray. After the gel was completely solidified, it was mounted in the electrophoresis tank. Then the tank was filled 
with 1X alkaline electrophoresis buffer until the gel was covered with the buffer at a depth of 3–5 mm above the 
gel. DNA samples after AAG and APE1 digestion were collected and 6X alkaline gel-loading buffer (300 mM 
NaOH, 6 mM EDTA, 18% Ficoll, 0.15% Bromocresol green, 0.25% Xylene cyanol) was added to each sample. 
Chelating all  Mg2+ with EDTA (component of the 6X alkaline gel-loading buffer) is important before loading the 
samples onto the alkaline agarose gel because in solutions with a high pH,  Mg2+ can form insoluble Mg (OH)2 
precipitates that entrap DNA and inhibit DNA mobility through the gel. Samples were loaded and the gel was 
run at room temperature at 30 V for 19–24 h. Alternatively, the electrophoresis can be run at 4 °C in a cold room. 
We found that running the gel in a cold room helped improve the sharpness of the DNA bands. Note that after 
the run is completed, the Bromocresol green dye may not be visible because of dye diffusion in the gel. The gel 
was transferred to a large plexiglas tray, covered with neutralizing solution (1 M Tris–HCl pH 7.6, 1.5 M NaCl), 
and incubated for 30 min with gentle shaking on an orbital shaker. Next the gel was transferred to staining solu-
tion (1X TAE buffer with SYBR gold) and stained for 1 h with gentle shaking. The container with the gel was 
covered with aluminum foil to protect the staining solution from light. Following staining, the gel was rinsed and 
de-stained with  H20 for 30 min with gentle shaking.
Equipment and settings. Images of the gels were acquired using the AI600 Imager (Amersham), by per-
forming fluorescence Epi-RGB blue light (460 nm), filter Cy2 capture with automatic exposure.
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Quantitative analysis of DNA damage and repair following MMS treatment. Quantitation of 
methylated bases in genomic DNA was performed on phosphor image data by using ImageQuant TL 8.2 soft-
ware (Cytiva) and number-average DNA length analysis. The number-average length of genomic DNA (± AAG/
APE treatment) was used to calculate the average number of SSBs/kb, and the percentage of MDAs removed (% 
repair) was determined as described  previously49,51. Briefly, using the ImageQuant software functions, each data 
point on the gel image is marked with a box encompassing the entire length of the lane to give the total area of 
each lane. The data point corresponding to 1/2 the total area, designated as Xmed, is then determined. The Xmed 
value indicates the median migration distance of the DNA fragments. Xmed is converted to the median length Lmed 
of DNA molecules by using a standard curve generated from the migration of DNA-size markers. The number 
average molecular length, Ln, is calculated from Lmed by using the equation Ln = 0.6 Lmed54, assuming a Poisson 
distribution of DNA fragments. Numbers of SSBs/kb is calculated using the following equation; SSBs/kb = 1/Ln 
(+ AAG + APE1) − 1/Ln (-AAG-APE1). Calculated numbers of SSBs per kb DNA fragment indicate numbers of 
MDAs.
DNA damage and time course of repair in multicellular fungus Neurospora crassa. Liquid cul-
tures of N. crassa were grown for 11 h in VMM (Vogel’s minimal medium) media in an orbital shaker at 30 °C. 
MMS was added to liquid cultures at a final concentration of 3.5 mM. Cells were incubated in the presence of 
MMS for 3 h. Next, the cells were collected by using a Buchnner funnel, and washed with 500 ml of VMM media 
to remove MMS. Washed cells were transferred to pre-warmed VMM media and then allowed to grow at 30 °C 
for 4 h to enable repair of damaged DNA. Aliquots of cells were harvested and immediately frozen in liquid 
nitrogen. Genomic DNA was isolated and 300 ng of genomic DNA was digested with APE1 endonuclease (cat 
# M0282S, New England Biolabs), AAG glycosylase (cat # M0313S, New England Biolabs), or both enzymes 
in MOPS reaction buffer (70 mM MOPS, pH 7.5,1 mM dithiothreitol DTT, 1 mM EDTA, 5% glycerol) for 1 h 
and 15 min at 37 °C. Reactions were stopped by adding alkaline DNA loading buffer (50 mM NaOH, 1 mM 
EDTA, 3% Ficoll). Samples were resolved on a 1.2% alkaline agarose gel. Agarose gels were run in a cold room 
at 25 V for 17 h and then incubated in neutralization buffer (1.5 M NaCl, 1 M Tris–Cl pH 7.6) for 45 min before 
being stained with SYBR Gold (cat # S-11494, Life Technologies) for 40 min and de-stained for 30 min before 
 imaging55.
DNA damage and time course of repair in human cells. Human adrenal carcinoma cells (SW13) 
were a gift from Dr. Feng Gong laboratory at the University of Miami. Human fibroblast CHON-002 were a gift 
from Dr. Rafael Contreras laboratory at the Hormel Institute, University of Minnesota. Human haploid HAP1 
cells were purchased from Horizon Discovery Biosciences. SW13 cells were cultured in DMEM (Sigma, cat# 
D5796) supplemented with 10% fetal bovine serum FBS (Gibco, cat# 26140-079). Human fibroblast CHON-002, 
leukemia HAP1, and lymphoblastoid cells GM12878 were cultured according the ATCC guidelines. Cell cul-
tures were routinely tested for mycoplasma by using a mycoplasma detection kit (ATCC, cat# 30-1012 K). Cell 
doubling time was determined following ATCC guidelines and viability was routinely monitored with trypan 
blue. Cells were seeded in T25 flasks (~ 500,000 cells per dish) and grown for 16–24 h until cells reached 60–70% 
confluence. One T25 flask was set for each data point to be collected. In DNA damage dose response experi-
ments SW13 cells were treated with (0- 20 mM) MMS in 1XPBS for 10 min at RT (room temperature). In DNA 
damage and repair experiments, SW13 cells were treated with 10 mM (0.1%) MMS for 10 min in 1xPBS at RT, 
or alternatively ice-cold, serum-free media can be also used for MMS treatments. Ice-cold treatment is used to 
inhibit endogenous background BER during the MMS treatment. MMS was removed and cells were washed 
with 1X PBS. Next, fresh pre-warmed media were added and cells were allowed to repair for 0, 3, 8, or 22 h. GM 
12878 cells were treated with 5 mM (0.05%) MMS for 5 min. Total genomic DNA was purified from each time 
point using the PureLink genomic DNA mini kit (K 182001, Thermo Fisher Scientific). DNA was processed with 
AAG and APE1 enzymes as described above. DNA was resolved on a 1.2% alkaline agarose gel, run at 30 V for 
22 h, stained with SYBR gold, and quantified as described above.
Western Blotting. HAP1, SW13 and CHON-002 cells were harvested and frozen at − 80 °C. Protein extracts 
were prepared in a RIPA buffer (Santa Cruz, sc-24948) plus phosphatase inhibitor (Santa Cruz, sc-45044 and 
sc-45044) and equal amounts of protein were separated on TGX stain-free (Bio-Rad, cat#5678083). Proteins 
were transferred onto TransBlot LF PVDF (Bio-Rad) and analyzed by Western blotting using antibodies recog-
nizing the following proteins: AAG (Abcam ab155092, 42KD, 1:5000), beta-actin (Sigma A5441, 33KD, 1:5000).
Results
Alk‑BER assay workflow. The conserved nature of the BER pathway enables easy adaptation of the assay 
to various cell types and model organisms from lower eukaryotes to human cells. We initially developed the 
alk-BER assay to measure BER in yeast cells (S. cerevisiae) and successfully adapted the assay to other fungal 
model organism (N. crassa) and human cells. The alk-BER assay is based on the enzymatic conversion of the 
MMS-induced damaged DNA bases to single strand breaks (SSBs), which are subsequently resolved on alkaline 
agarose gels and quantified. The rate of BER can be analyzed by performing a DNA damage and time course for 
repair and assessing the rate of removal of damaged bases from the total genomic DNA. The assay is performed 
in 5 simple steps (Fig. 1) and can be completed in 3 days. The first step involves exposing the cells to sub-lethal 
doses of MMS to induce formation of methyl DNA adducts (mainly 7meG and 3meA). In the second step, 
cell aliquots corresponding with DNA damage and repair time points are collected and total genomic DNA is 
isolated. The third step involves conversion of MDAs to SSBs with BER enzymes (AAG glycosylase and APE1 
endonuclease) that specifically bind and cleave the DNA at sites of MDAs. The fourth step involves running the 
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samples on alkaline agarose gels to separate DNA fragments containing SSBs from the bulk genomic DNA that 
does not contain damage. The final step involves staining of the separated DNA fragments in the gel, acquiring 
an image of the gel and performing quantitation of MDAs. The alk-BER method directly quantifies the num-
bers of MDAs in purified genomic DNA and analyzes the kinetics of DNA repair at the whole-genome level. 
In order to assess the capacity of BER using the alk-BER assay, cells should be exposed to sub-lethal doses of 
MMS, that induce detectable levels of MDAs, but do not induce substantial cell death. To determine sub-lethal 
doses for specific cell line it is recommended to perform MMS dose response experiment encompassing range 
of MMS doses from low to high. Cell death is induced when unrepaired lesions persist due to inability of BER to 
efficiently repair abnormally high levels of DNA damage or when BER activity is compromised (e.g., BER gene 
mutants). BER capacity should also be analyzed within a specific, experimentally determined window of time 
following DNA damage, typically 0–3 h for yeast cells, or 0–24 h for human cells, to avoid interference from 
lesion bypass and DNA replication.
Alk‑BER in fungal cells. A DNA damage dose response assay was performed by exposing yeast cells (strain 
BY4741) to increasing doses of MMS (5, 10, 20 mM) for 10 min at 30 °C. Total genomic DNA was isolated 
and treated with AAG and APE1 enzymes. DNA samples were resolved by alkaline agarose gel electrophoresis 
and numbers of MDAs were quantified as described above. As the gel is run at alkaline pH, hydrogen bonding 
between the two DNA strands is broken to facilitate separation of strands containing breaks from non-damaged 
genomic DNA. The denatured DNA is maintained in a single-stranded state and migrates through the alkaline 
gel as a function of its size, forming a distinct smear. Increased formation of MMS-induced DNA lesions in 
response to increased doses of MMS is shown as increases in lower molecular weight DNA molecules, also vis-
ible as a smear (Fig. 2A). The frequency of MDAs (7meG and 3meA) was calculated and plotted as the number of 
methyl A, G per kb fragment as a function of increasing doses of MMS (Fig. 2B). The proportional relationship 
between increasing MMS doses and numbers of MDAs indicates a high sensitivity of the alk-BER method, ~ 1.0 
MDAs per 10,000 bases, that is induced by 5 mM MMS dose, and ~ 4.0 MDAs per 10,000 bases induced by 
20 mM MMS in yeast cells (Fig. 2B).
Figure 1.  Schematic outline of alk-BER assay. The assay involves exposing the cells to MMS (step 1), isolation 
of total genomic DNA (step 2), conversion of MMS-induced methylated bases to SSBs with damage specific 
enzymes AAG and APE1 (step 3), separation of DNA fragments containing SSBs by alkaline agarose gel 
electrophoresis (step 4), gel staining, imaging, and quantitation of MDAs (step 5).
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DNA damage and time course of repair has been performed to evaluate the overall rate of BER to repair 
alkylation DNA damage in the yeast wild type strain BY4741. DNA molecules containing MMS-induced MDAs 
are converted to SSBs. Proficient DNA repair and restoration of genome integrity can be visually monitored as 
progressive shortening of the DNA smear in migration and restoration of the genome integrity by formation of 
high molecular weight DNA. DNA was processed with AAG and APE1 and resolved on alkaline agarose gels as 
described previously. A representative gel image demonstrating DNA damage and repair in the BY4741 yeast 
strain is shown (Fig. 2C) and corresponding quantitative analysis of the gel is also shown (Fig. 2D). BER in the 
WT BY4741 yeast strain is proficient, and over 80% of the total MDAs in the genome are repaired after 3 h repair 
time at the dose used (Fig. 2D). The specificity of the alk-BER method was validated using yeast and Neurospora 
mutant cells deficient in BER. The yeast mag1∆ mutant has no Mag1 glycosylase (orthologue of human AAG) 
and is deficient in cleaving MMS-induced 7meG and 3meA from the DNA. Cells from the WT and mag1∆ 
strains were exposed to MMS for a total of 3 h followed by MMS removal and a 6 h-long repair time course to 
allow cells to repair damaged DNA. During the 3 h-long MMS exposure, mutant cells displayed higher levels of 
MDA formation as compared to WT because endogenous BER is inactive in the mutant cells, which results in 
accumulation of MDAs under the conditions of continuous MMS exposure. After removal of MMS, WT cells 
with proficient BER were able to clear most of the lesions during the repair time course, whereas BER-deficient 
mag1∆ cells contained high levels of unrepaired MDAs (Fig. 3A–C). The alk-BER assay was successfully adapted 
to multicellular fungal model Neurospora crassa. DNA damage and repair time course was performed with 
Neurospora WT and mag1∆  cells55. Neurospora cells of the wild type laboratory strain were exposed to 3.5 mM 
MMS continuously for 3 h, followed by repair time course in media without MMS for 5 h. Genomic DNA was 
isolated and processed with combinations of AAG and APE1 enzymes and resolved on alkaline agarose gel. BER 
Figure 2.  Alk-BER assay in yeast cells (S. cerevisiae). (A) Representative alkaline agarose gel image of MMS-
induced DNA damage dose response in the BY4741 strain of S. cerevisiae. Genomic DNA of cells not exposed 
to MMS (C: control), and DNA of cells exposed to increasing doses of MMS (5, 10, or 20 mM) was resolved 
on alkaline agarose gel. Each DNA sample was treated with (+) and without (−) a cocktail of AAG and APE1 
enzymes. (B) Dose dependent increase in the numbers of MMS-induced methyl G, A per 1 kb DNA fragment. 
Each data point denotes the average value and standard deviation of three independent experiments. (C) 
Representative gel image of DNA damage and repair time course in the BY4741 strain of S. cerevisiae. M: DNA 
size standard lambda/HindIII. C: control, cells not exposed to MMS, 0: cells collected after 10 min exposure to 
20 mM MMS, 1–3 h: cells collected after 1, 2, 3 h of repair. (D) Quantitative representation of data displayed 
in panel C. Formation and repair of MMS-induced methyl G and A (7meG, 3meA), as a function of repair 
time. Each data point represents an average of 3 independent experiments; error bars were calculated based 
on standard deviation. Gel image presented in panel (A) has been cropped. Original, uncropped gel image is 
included in the supplementary data.
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capacity to repair MMS-induced lesions in Neurospora cells is very efficient, with nearly complete restoration of 
genome integrity following 2 h repair period (Fig.S2).
Alk‑BER in human cells. The human adrenal carcinoma SW13 cell line was used to adapt and optimize 
the alk-BER assay for assessing rates of BER in human cells. A series of MMS-dose response experiments were 
initially performed to determine the appropriate range of MMS concentration and time of the exposure for 
induction of detectable levels of MDAs at sub-lethal MMS doses. Cell viability was routinely monitored with 
trypan  blue56. Representative MMS dose response data are presented in Fig. 4A,B. Increases in the smear length 
in response to increasing doses of MMS in the (+ AAG&APE1) lanes indicate enhanced formation of MDAs. 
The minimal smear in (− AAG&APE1) lanes reveals formation of MDA-derived BER intermediate AP sites and 
SSBs that form in DNA as a result of the continuous activity of endogenous BER during MMS exposure. AP sites 
are fragile in alkaline conditions and can spontaneously convert to SSBs contributing to the smear in (-enzyme) 
lanes. The proportional relationship between increasing MMS doses and numbers of MDAs indicates a high 
sensitivity of the alk-BER method, ~ 0.7 MDAs per 10,000 bases with 5 mM MMS dose in human cells. Efficiency 
of the individual enzymes, AAG and APE1 to convert MMS-induced MDAs to SSB in genomic DNA was assess. 
We found that the cocktail of both enzymes AAG and APE1 works most efficient in converting MDAs to SSBs 
(Fig. 4C). The BER capacity in SW13 cells was analyzed by performing DNA damage and a time course of repair 
as described in the methods section. Cells were exposed to 10 mM MMS for 10 min in 1X PBS at RT, followed 
by removal of MMS and repair for 22 h in fresh media. The MMS dose used was a sublethal dose, that did not 
trigger significant cell death, as demonstrated by the cell viability data (Fig. 4F). After 22 h post MMS exposure 
nearly 70% of the genome was restored in SW13 cells. Representative data showing the image of the alkaline aga-
rose gel and data quantitation are presented (Fig. 4D,E). Other human cell lines were subject to alk-BER assay, 
including untransformed fibroblast cells CHON-002, and leukemia cancer cells HAP1. The BER capacity to 
remove MMS-induced adducts was quantitated over distinct repair time points. The removal of MDAs appears 
very slow (~ 0–30% repair) during the first 0-8 h post MMS exposure and is consistently observed in many dif-
ferent human cell lines we tested. Interestingly, the repair rates vary significantly between different cell lines, and 
unlike in fungal cells, the rates do not appear to correlate well with the levels of AAG enzyme in the panel of 
cell lines we tested (Fig. 5A,B). Additionally, alk-BER assay was performed with human lymphoblastoid cell line 
GM12878. Cells were exposed to 5 mM MMS for 5 min, and repair rate was analyzed at 2.5 and 5 h in the repair 
time in media without MMS. Clearly, very slow repair was detected during the initial 5 h repair (Fig. S3). Speci-
ficity of alk-BER was analyzed by exposing SW13 cells to increasing doses of oxidative agent hydrogen peroxide 
(H2O2), and temozolomide (TMZ), clinically used SN1 alkylator, known to induce 7meG, 3meA and O6meG 
 adducts57. Exposure to H2O2 does not result in formation of a dose-dependent DNA smear, indicating that alk-
BER assay is specific to methyl adducts, and it cannot detect oxidative DNA damage (Fig. S1A). As expected, 
alk-BER can specifically detect TMZ-induced DNA methyl adducts in a dose dependent manner (Fig. S1B,C), 
although the TMZ potency to induce MDAs  appears lower than the potency of MMS.
Discussion
The efficiency of BER in repairing alkylation DNA damage varies substantially between different cells, tissues, 
and individuals, and has important implications in cancer development and  treatment1,2,58,59. BER efficiency is 
a result of a complex interplay between genetic and epigenetic factors influencing the abundance and activity of 
Figure 3.  Alk-BER assay validation with BER-deficient yeast mutant cells, mag1∆. (A) The BER rate was 
analyzed in mag1∆ mutant. WT and mutant cells were treated with 3.5 mM MMS for 1–3 h, followed by 
removal of media containing MMS and repair time course in fresh media for 1–6 h. (B) Repair rates expressed 
as a function of % of methyl A, G removed over the repair time. (C) Cells were treated with 20 mM MMS for 
10 min followed by repair time course for total of 3 h. Repair rates expressed as a function of % of methyl A, G 
removed over the repair time. Each data point represents an average of two independent experiments.
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Figure 4.  Alk-BER assay in human cells. (A) MMS dose response in SW13 cells. Cells were treated 
with increasing doses of MMS for 10 min at RT. Representative alkaline agarose gel image is shown. (B) 
Quantification of methyl A, G per 1 kb DNA fragment as a function of increasing MMS dose. The graph 
represents quantification of the data in panel (A). (C) Efficiency of double enzyme (AAG&APE1), and single 
enzymes: (AAG only), and (APE1 only), in converting methyl DNA adducts to SSBs. (D) Alkaline gel image 
representing DNA damage and repair time course. SW13 cells were exposed to 10 mM MMS for 10 min. 
Genomic DNA was isolated, and processed with double enzyme AAG&APE1 digest. (E) Quantification of the 
repair and removal of methyl A,G as a function of time. (F) SW13 cell viability measured by trypan blue. Each 
data point represents an average of 3 independent experiments; error bars were calculated based on standard 
deviation. Gel image presented in panel (C) has been cropped. Original, uncropped gel image is included in the 
supplementary data.
Figure 5.  The repair of MDAs is slow in human cells and does not correlate well with the levels of endogenous 
AAG enzyme. DNA damage and repair time course experiment was performed in several human cell lines; 
CHON-002, SW13, and HAP1. Cells (60–70% confluent) were exposed to 10 mM (0.1%) MMS in 1xPBS 
for 10 min at RT, followed by DNA repair time course 0, 3, 8 and 22 h at 37 °C. (A) DNA repair rates were 
quantitated individually for each cell line and expressed as a percentage (%) of the removed methyl A,G, as 
compared to the 0 h time point. Each data point represents an average of two independent experiments. (B) 
Endogenous levels of AAG enzyme were detected by Western blotting. Western blot image presented in panel 
(B) has been cropped. Original, uncropped blot image is included in the supplementary data.
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the BER enzymes, and the individual steps in the BER pathway. Ability to measure the formation and rates of 
repair of alkyl DNA adducts in genomic DNA provides a direct assessment of BER efficiency in a given cell type.
Here, we report a quantitative cell-based assay, alk-BER (alkylation Base Excision Repair), developed for 
measuring efficiency and rates of BER following alkylation DNA damage in fungal model organisms (S. cerevisiae, 
N. crassa) and human cell lines (SW13, CHON-002, HAP1 and GM12878). Alk-BER offers a simple, time- and 
cost-efficient, cell-based method for quantitative analysis of alkylation DNA damage and repair in the genomic 
DNA. The alk-BER assay can be used to determine BER efficiency in various cell types, by assessment of the rates 
of methyl DNA adducts removal from the DNA over time.
Alk-BER has been developed as an adaptation and extension of the previous methods pioneered by Sutherland 
et al., to quantify UV-induced DNA damage and  repair48. The original methods were based on quantification of 
DNA migration in ethidium bromide-stained alkaline agarose gels and scanning the image on film negatives with 
a densitometer. Alk-BER method reported here relies on the similar principles of quantifying DNA damage from 
alkaline agarose gels, but alk-BER assay has been developed and optimized specifically for the analysis of DNA 
alkylation repair. In addition, alk-BER involves several technological advances that improve method sensitivity 
and overcome many of the limitations of quantifying DNA from ethidium bromide fluorescence, including the 
linear range of detection. For example, we use SYBR Gold fluorescent dye to stain DNA in the gel. SYBR gold 
is about tenfold more sensitive than ethidium  bromide60. SYBR gold also has increased signal to background 
ratio, as demonstrated by more than 1000-fold signal enhancement when bound to nucleic acids, which is 
approximately 50 times greater than that of ethidium  bromide60. Furthermore, in our method gel images are 
acquired with modern, highly sensitive imaging systems (e.g., ChemiDoc MP, Bio-Rad) that allow for significant 
improvements of the linear dynamic range of detection. The improved linear range of detection permits accurate 
quantification of the DNA from a gel, where there is large variability in DNA band intensity (e.g. low intensity 
when bands disappear right after damage, and high intensity when bands reappear during repair)51. In summary, 
we adapted the principles of quantifying DNA damage from alkaline gel electrophoresis to analyze repair of DNA 
alkylation, and extended the method to analyze repair by BER at the genome level in various model organisms, 
including fungal cells (S. cerevisiae, N. crassa) and human cancer cell lines.
Yeast cells have been extensively used to study DNA repair processes in eukaryotic  cells61. Yeast have a robust 
and conserved BER pathway to repair alkylation DNA damage. Using alk-BER assay, we found that in wild type 
strains of fungal model organisms (S. cerevisiae and N. crassa), BER proceeds quite rapidly, following removal of 
the MMS from the growth media. We showed that BER in the BY4741 strain of S. cerevisiae is nearly completed 
within 3–4 h post exposure since nearly 80–90% of the lesions were removed from the genome (Fig. 2C,D). 
Similarly, repair of alkylation DNA damage has been nearly completed within 2–4 h in the wild type laboratory 
strain of N. crassa55 (Fig. S2). We also showed that BER-deficient mag1∆ yeast mutant cells were deficient to 
clear MMS-induced lesions and accumulated MDAs over time, which validates specificity of the alk-BER assay 
(Fig. 3A–C). The human genome is much larger therefore repair is expected to take longer as compared to lower 
eukaryotes having smaller genomes. We found that the majority of the genome (~ 70% lesions removed) was 
restored following 22 h post MMS exposure in SW13 cells (Figs. 4D,E, 5A), which is consistent with previous 
studies reporting that majority of DNA alkylation repair in mammalian cells can be completed within 24 h post 
exposure, as revealed by results generated with various quantification  methods39,62–66. We found that the rates of 
BER to remove MMS-induced DNA adducts vary significantly between SW13 and CHON-002, and HAP1 cell 
lines and do not correlate well with the endogenous levels of AAG enzyme in these cell lines (Fig. 5A,B). These 
rates can be influenced by the endogenous levels and activities of various BER enzymes, including additional 
glycosylases, and other regulators of DNA repair. Future studies are needed to further investigate the mechanisms 
and regulators of DNA alkylation repair in human cells.
We found that in lower eukaryotes (S. cerevisiae, N. crassa), the rate of repair of MMS-induced methyl DNA 
adducts is strongly dependent on the functional MAG1 glycosylase, where mag1∆ mutants demonstrate abol-
ished ability to repair MDAs. Interestingly, repair of MDAs in certain mammalian cells does not appear to be 
exclusively dependent on AAG glycosylase. It has been reported that the alkylated bases 3meA and 7meG, both 
AAG substrates generated from MMS treatment, are removed from the genome of AAG-deficient embryonic 
stem cells, with slower kinetics for 3meA but comparable kinetics for  7meG67. Other study revealed that similar 
levels of 7meG were detected in livers of AAG +/+ and AAG −/− mice 24 h after exposure to  MNU68. These studies 
suggest that in mammalian cells methyl DNA adducts can be excised and repaired in the absence of AAG enzyme, 
perhaps by involvement of other glycosylases, or spontaneous depurination. Future application of alk-BER could 
facilitate further understanding of the role of AAG and other factors in regulation of human BER.
The rates of repair of DNA alkylation can vary significantly between different organisms and cell types, and 
can be influenced by the levels and activities of the BER enzymes, genome size, chromosome landscape, DNA 
replication and translesion DNA synthesis (TSL). Therefore, it is necessary to experimentally determine a time 
range for accurate analysis of BER activity for each cell type under study. This is accomplished by carefully moni-
toring DNA damage induction and repair over a repair time course. The time range for BER to repair alkylation 
lesions is also dependent on the cell doubling time, which is much shorter (~ 90 min) in yeast cells, and longer 
(~ 16-24 h) in human cancer cell lines. It should be noted that exposure to DNA damage triggers transient cell 
cycle arrest as part of DNA damage response, that allows the time for DNA repair to take place before the next 
round of cell  division69. The activity of BER should be analyzed immediately after induction of DNA damage, and 
within the 3–4 h for S. cerevisiae and Neurospora, and 24-48 h in human cell lines, when majority of the lesions 
are expected to be repaired by BER. After majority of lesions have been repaired, the DNA replication and cell 
cycle progression will resume. A small proportion of DNA base lesions, those which are left unrepaired, can 
be bypassed by translesion DNA synthesis (TSL) that occurs during DNA replication. TSL involves specialized 
replicative polymerases, which can perform error-free DNA synthesis over DNA base  lesions70. Therefore, in 
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order to avoid possible interference from DNA replication and lesion bypass, BER activity should be analyzed 
at early repair time points and within experimentally determined cell-specific time rage.
The alk-BER could serve as useful framework for number of approaches to study repair of DNA alkylation. 
For example, alk-BER assay could be used to distinguish, in a quantitative way, between the levels of MDAs and 
levels of downstream repair intermediates, such as AP sites. Highly specific and sensitive detection of AP sites 
could also be performed by processing of the sample with the AAG enzyme only (converts MDA to AP sites) 
and subsequent detection of AP sites using a highly sensitive AP site detection kit (e.g., Abcam, ab 211154). Alk-
BER assay can also serve as a framework for quantification of gene-specific repair when coupled with Southern 
blot and hybridization of gene-specific probes. Alk-BER could also be useful in detection and quantification of 
MMS-induced methyl DNA adducts in preparation and optimization of samples for the approaches involving 
next generation sequencing, such as NMP-seq.
In summary, the alk-BER assay offers a versatile, reliable and affordable approach for quantitative analysis 
of DNA damage formation and repair following exposure to DNA methylating alkylating agents. The alk-BER 
assay can be easily optimized to be used in any type of cultured cells, and integrated with the existing approaches 
to study mechanisms regulating BER balance and capacity. The assay has the ability to detect imbalances in the 
activity of the BER process, that is highly relevant to cancer development and treatment. Quantitative analyses 
of DNA alkylation damage and repair using fungal genetic model organisms and human cell lines offer unique 
opportunities to identify novel, conserved regulators of BER.
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